Best Biopharma Outsourcing Companies in New York City, United States
The 56 best Biopharma Outsourcing companies in New York City, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: OnCusp.
Our analysis of 50 Biopharma Outsourcing companies
$6.3b in tracked funding; 77% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in New York City
| # | Company | Employees | Disclosed funding | Last round | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ACM Global Central Laboratory Global central lab providing clinical trial, bioanalytical, and toxicology services | 17,000 | — | — | — | Priority HintsUserWayjQuery+4 | Top 10M | — | — |
| 2 | Campana & Schott Technology consultancy company focused on life science sector | 564 | — | — | — | TYPO3 CMSApple iCloud MailMicrosoft 365+14 | Top 5M | — | — |
| 3 | Flourish Research CRO focused on providing clinical trial, phase I-IV, and research sites | 267 | — | — | Reinhold Schulz CEO | WordPressApple iCloud MailMicrosoft 365+41 | Top 5M | — | — |
| 4 | MCRA Provider of regulatory, quality assurance and market access services to biopharma sector | 198 | — | 101 mo ago | — | DrupalMariaDBPHP+20 | Top 5M | — | — |
| 5 | Clinilabs A full-service contract research organisation | 195 | — | 16 mo ago | — | WordPressMySQLPHP+29 | Top 5M | 13 patents Digital platforms for online clinical trial recruitment, patient referral, and efficacy data reporting | 1 job opening · 1 partnership |
| 6 | Aceto Traditional company manufacturing APIs, intermediates, formulations and chemicals | 164 | — | 128 mo ago | — | — | — | 4 patents Odor control technologies for organic waste and landfill gas treatment | — |
| 7 | NewPage Solutions Provider of remote patient monitoring platform for doctors | 109 | — | — | Syed Arshad CEO | WordPressApple iCloud MailMicrosoft 365+9 | Top 10M | 89 patents Inkjet recording media formulations and substrate technologies for high‑quality printing | — |
| 8 | KPS Life CRO offering full and functional services for clinical development | 101 | $4M | 10 mo ago | David Kelly Founder & CEO | WordPress Block EditorWordPressApple iCloud Mail+29 | Top 10M | — | — |
| 9 | Syntactx CRO that assists medical device, pharmaceutical, and diagnostic laboratory companies with the design and… | 90 | $512K | 73 mo ago | — | — | — | — | — |
Top 12 Biopharma Outsourcing companies in New York City
#1
Series C · New York City, New York · founded 2022 · 13 employees$36Mraised▾
CRO focused on providing fermentation products manufacturing and commercialisation services
- Jan 2025Series C$52M
- Oct 2024Grant (prize money)$1.4M
- Apr 2024Series A$19M
- Nov 2023Conventional Debt$25M
#2
Seed · New York City, New York · founded 2006 · 101 employees$3.5Mraised▾
Kellman Pharmaceutical Services (KPS) is a full service CRO and a functional service provider offering its services to the pharmaceutical, biotech, and medical device industries. They offer their services for clinical operations, quality assurance, data management, drug safety and regulatory affairs. They can also provide qualified clinical resources to be assigned to specific outsourced tasks such as clinical monitoring, project management, and others. They offer their services for Phase I - IV clinical trials and have therapeutic experience in oncology, CNS, hematology, infectious disease, rare and ultra-rare diseases, vaccines, pediatrics, women's health, endocrinology and several others.
- Sep 2025Seed$1.2M
- Jun 2025Seed$2.3M
#3
Series A · New York City, New York · founded 2021 · 15 employees$139Mraised▾
CRO offering clinical development services for oncology drugs
- Jan 2024Series A$100M
- Seed—
#4
Series B · New York City, New York · founded 2019 · 55 employees$16.6Mraised▾
Provider of preclinical development services
- Aug 2022Series B$16.6M
#5
Seed · New York City, New York · founded 2003 · 4 employees$1.5Mraised▾
NexGenix Pharmaceuticals is a privately-held drug discovery and development company focused on the "next generation" of targeted therapies for cancer. They have a growing portfolio of intellectual property covering their key efforts.
- Aug 2023Seed$1.1M
- Apr 2010Grant (prize money)$320K
- Sep 2009Grant (prize money)$117.5K
#6
Funding Raised · New York City, New York · founded 2022$255.4Kraised▾
Provider of commercialization and clinical development solutions for life science companies. The organization offers services across the product lifecycle, from early-stage development through post-launch. Its capabilities include strategic consulting, medical affairs, marketing, and engagement. The company combines expertise with technology to deliver tailored solutions.
- Sep 2022Grant (prize money)$255.4K
#7
Seed · New York City, New York · founded 2015$547.5Kraised▾
Provider of business strategy, marketing, and other services for drug development industries
- May 2021Seed$547.5K
#8
Funding Raised · New York City, New York · founded 1998$1.2Mraised▾
Foundation aims to discover drugs to prevent, treat, and cure alzheimer's disease. It also provides early-stage research, clinical trials, and support to scientists and institutions. It also provides resources for the public through its Cognitive Vitality platform, offering information on brain health and aging.
- Nov 2010Grant (prize money)$343.5K
- Sep 2010Grant (prize money)$75K
- Sep 2008Grant (prize money)$343.5K
- Sep 2007Grant (prize money)$418.5K
#9
Acquired · New York City, New York · founded 2010 · 90 employees$511.8Kraised▾
CRO that assists medical device, pharmaceutical, and diagnostic laboratory companies with the design and execution of clinical research trials.
- Jun 2020Grant (prize money)$511.8K
#10
Funding Raised · New York City, New York · founded 2018$225Kraised▾
Provider of imaging-focused clinical trial support services. This includes advising on trial design and biomarker selection, implementing imaging methodologies in research studies and trials, and assisting with grant proposals. The services aim to improve health outcomes by enhancing clinical trial efficiency through the use of sensitive imaging markers to refine enrollment criteria and expand clinically meaningful endpoints. This ultimately increases the likelihood of successful trial completion.
- Jan 2018Grant (prize money)$225K
#11
Seed · New York City, New York · founded 2016 · 4 employees$120Kraised▾
Bayesian computational oncology, providing Stan-based modeling, optimization, and a HIPAA-compliant cloud. They leverage Bayesian scientific computing to connect low-level measurements to clinically meaningful outcomes. Their services include model development, optimization, and training, utilizing a computational cloud. They address questions related to biomarker prediction, responder differentiation, patient progression, treatment effectiveness, and optimal dosing. Their models are defined explicitly through code, ensuring explainability and transparency. They utilize advanced computational statistics, such as dynamic Hamiltonian Monte Carlo and Pathfinder Variational Inference, to fit complex hierarchical models. Bayesian methods support well-calibrated predictions by generating full probability distributions. Their models excel in small data regimes, leveraging prior knowledge from various sources. They offer solutions for Pharma and Biotech companies, focusing on predictive accuracy and calibration. This is a B2B tech company offering software and cloud-based solutions.
- 2017Seed$120K
#12
Late Stage · New York City, New York · founded 2001 · 195 employees—raised▾
Clinilabs is a full-service contract research organisation that provides clinical development services to pharma, biotechnology, & medical device companies. Their services include Project Management, Monitoring, Medical Writing, Site Selection, Auditing, IRB Submissions, Data Management, Programming, Biostatistics and Technology Solutions.
- Mar 2025PE—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
- Genentech18103
- UNIV California17969
- Regeneron Pharma16083
- Amgen10510
- Monsanto Technology9754
- UNIV Pennsylvania8526
- Harvard College7463
- UNIV Texas7382
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.